REQUEST A DEMO
Total
USD $0.00
Search more companies

Plg Pharmaceuticals Private Limited (India)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Plg Pharmaceuticals Private Limited Profile Updated: April 02, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Plg Pharmaceuticals Private Limited is a company in India, with a head office in North West Delhi. The company operates in the Pharmaceutical and Medicine Manufacturing industry. It was established on April 25, 2005. The latest financial highlights indicate a net sales revenue drop of 20.1% in 2024. Over the same period, its total assets decreased by 38.25%. The net profit margin of Plg Pharmaceuticals Private Limited decreased by 0.07% in 2024.

Legal Address
24/20, Village Budhpur
North West Delhi; Delhi; Postal Code: 110036

Contact Details: Purchase the Plg Pharmaceuticals Private Limited report to view the information.

Basic Information
Registered Capital:
Purchase the Plg Pharmaceuticals Private Limited report to view the information.
Financial Auditors:
Purchase the Plg Pharmaceuticals Private Limited report to view the information.
Incorporation Date:
April 25, 2005
Key Executives
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Professional Director
Purchase this report to view the information.
Professional Director
Company Performance
Financial values in the chart are available after Plg Pharmaceuticals Private Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
-20.1%
Total Operating Revenue
-20.12%
Operating Profit
-19.38%
EBITDA
-13.04%
Net Profit/Loss for the Period
-26.97%
Total Assets
-38.25%
Total Equity
12.12%
Operating Profit Margin
0.01%
Net Profit Margin
-0.07%
Return on Equity (ROE)
-5.78%
Debt / Equity
21.82%
Quick Ratio
0%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?